BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

570 related articles for article (PubMed ID: 27861786)

  • 1. Infantile spasms and encephalopathy without preceding neonatal seizures caused by KCNQ2 R198Q, a gain-of-function variant.
    Millichap JJ; Miceli F; De Maria M; Keator C; Joshi N; Tran B; Soldovieri MV; Ambrosino P; Shashi V; Mikati MA; Cooper EC; Taglialatela M
    Epilepsia; 2017 Jan; 58(1):e10-e15. PubMed ID: 27861786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Kv7.2 mutation associated with early onset epileptic encephalopathy with suppression-burst enhances Kv7/M channel activity.
    Devaux J; Abidi A; Roubertie A; Molinari F; Becq H; Lacoste C; Villard L; Milh M; Aniksztejn L
    Epilepsia; 2016 May; 57(5):e87-93. PubMed ID: 27030113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neonatal nonepileptic myoclonus is a prominent clinical feature of KCNQ2 gain-of-function variants R201C and R201H.
    Mulkey SB; Ben-Zeev B; Nicolai J; Carroll JL; Grønborg S; Jiang YH; Joshi N; Kelly M; Koolen DA; Mikati MA; Park K; Pearl PL; Scheffer IE; Spillmann RC; Taglialatela M; Vieker S; Weckhuysen S; Cooper EC; Cilio MR
    Epilepsia; 2017 Mar; 58(3):436-445. PubMed ID: 28139826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epileptic Encephalopathy In A Patient With A Novel Variant In The Kv7.2 S2 Transmembrane Segment: Clinical, Genetic, and Functional Features.
    Soldovieri MV; Ambrosino P; Mosca I; Miceli F; Franco C; Canzoniero LMT; Kline-Fath B; Cooper EC; Venkatesan C; Taglialatela M
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31295832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted gene panel sequencing in early infantile onset developmental and epileptic encephalopathy.
    Na JH; Shin S; Yang D; Kim B; Kim HD; Kim S; Lee JS; Choi JR; Lee ST; Kang HC
    Brain Dev; 2020 Jun; 42(6):438-448. PubMed ID: 32139178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variable expressivity of a likely pathogenic variant in KCNQ2 in a three-generation pedigree presenting with intellectual disability with childhood onset seizures.
    Hewson S; Puka K; Mercimek-Mahmutoglu S
    Am J Med Genet A; 2017 Aug; 173(8):2226-2230. PubMed ID: 28602030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HCN1 mutation spectrum: from neonatal epileptic encephalopathy to benign generalized epilepsy and beyond.
    Marini C; Porro A; Rastetter A; Dalle C; Rivolta I; Bauer D; Oegema R; Nava C; Parrini E; Mei D; Mercer C; Dhamija R; Chambers C; Coubes C; Thévenon J; Kuentz P; Julia S; Pasquier L; Dubourg C; Carré W; Rosati A; Melani F; Pisano T; Giardino M; Innes AM; Alembik Y; Scheidecker S; Santos M; Figueiroa S; Garrido C; Fusco C; Frattini D; Spagnoli C; Binda A; Granata T; Ragona F; Freri E; Franceschetti S; Canafoglia L; Castellotti B; Gellera C; Milanesi R; Mancardi MM; Clark DR; Kok F; Helbig KL; Ichikawa S; Sadler L; Neupauerová J; Laššuthova P; Šterbová K; Laridon A; Brilstra E; Koeleman B; Lemke JR; Zara F; Striano P; Soblet J; Smits G; Deconinck N; Barbuti A; DiFrancesco D; LeGuern E; Guerrini R; Santoro B; Hamacher K; Thiel G; Moroni A; DiFrancesco JC; Depienne C
    Brain; 2018 Nov; 141(11):3160-3178. PubMed ID: 30351409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Personalized treatment with retigabine for pharmacoresistant epilepsy arising from a pathogenic variant in the KCNQ2 selectivity filter.
    Nissenkorn A; Kornilov P; Peretz A; Blumkin L; Heimer G; Ben-Zeev B; Attali B
    Epileptic Disord; 2021 Oct; 23(5):695-705. PubMed ID: 34519644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypic and functional assessment of two novel KCNQ2 gain-of-function variants Y141N and G239S and effects of amitriptyline treatment.
    Bayat A; Iavarone S; Miceli F; Jakobsen AV; Johannesen KM; Nikanorova M; Ploski R; Szymanska K; Flamini R; Cooper EC; Weckhuysen S; Taglialatela M; Møller RS
    Neurotherapeutics; 2024 Jan; 21(1):e00296. PubMed ID: 38241158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of KCNQ2 variants causing either benign neonatal epilepsy or developmental and epileptic encephalopathy.
    Goto A; Ishii A; Shibata M; Ihara Y; Cooper EC; Hirose S
    Epilepsia; 2019 Sep; 60(9):1870-1880. PubMed ID: 31418850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kv7.3 Compound Heterozygous Variants in Early Onset Encephalopathy Reveal Additive Contribution of C-Terminal Residues to PIP
    Ambrosino P; Freri E; Castellotti B; Soldovieri MV; Mosca I; Manocchio L; Gellera C; Canafoglia L; Franceschetti S; Salis B; Iraci N; Miceli F; Ragona F; Granata T; DiFrancesco JC; Taglialatela M
    Mol Neurobiol; 2018 Aug; 55(8):7009-7024. PubMed ID: 29383681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A recurrent KCNQ2 pore mutation causing early onset epileptic encephalopathy has a moderate effect on M current but alters subcellular localization of Kv7 channels.
    Abidi A; Devaux JJ; Molinari F; Alcaraz G; Michon FX; Sutera-Sardo J; Becq H; Lacoste C; Altuzarra C; Afenjar A; Mignot C; Doummar D; Isidor B; Guyen SN; Colin E; De La Vaissière S; Haye D; Trauffler A; Badens C; Prieur F; Lesca G; Villard L; Milh M; Aniksztejn L
    Neurobiol Dis; 2015 Aug; 80():80-92. PubMed ID: 26007637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early-onset epileptic encephalopathy caused by a reduced sensitivity of Kv7.2 potassium channels to phosphatidylinositol 4,5-bisphosphate.
    Soldovieri MV; Ambrosino P; Mosca I; De Maria M; Moretto E; Miceli F; Alaimo A; Iraci N; Manocchio L; Medoro A; Passafaro M; Taglialatela M
    Sci Rep; 2016 Dec; 6():38167. PubMed ID: 27905566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KCNQ2 R144 variants cause neurodevelopmental disability with language impairment and autistic features without neonatal seizures through a gain-of-function mechanism.
    Miceli F; Millevert C; Soldovieri MV; Mosca I; Ambrosino P; Carotenuto L; Schrader D; Lee HK; Riviello J; Hong W; Risen S; Emrick L; Amin H; Ville D; Edery P; de Bellescize J; Michaud V; Van-Gils J; Goizet C; Willemsen MH; Kleefstra T; Møller RS; Bayat A; Devinsky O; Sands T; Korenke GC; Kluger G; Mefford HC; Brilstra E; Lesca G; Milh M; Cooper EC; Taglialatela M; Weckhuysen S
    EBioMedicine; 2022 Jul; 81():104130. PubMed ID: 35780567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced axonal surface expression and phosphoinositide sensitivity in K
    Kim EC; Zhang J; Pang W; Wang S; Lee KY; Cavaretta JP; Walters J; Procko E; Tsai NP; Chung HJ
    Neurobiol Dis; 2018 Oct; 118():76-93. PubMed ID: 30008368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extending the KCNQ2 encephalopathy spectrum: clinical and neuroimaging findings in 17 patients.
    Weckhuysen S; Ivanovic V; Hendrickx R; Van Coster R; Hjalgrim H; Møller RS; Grønborg S; Schoonjans AS; Ceulemans B; Heavin SB; Eltze C; Horvath R; Casara G; Pisano T; Giordano L; Rostasy K; Haberlandt E; Albrecht B; Bevot A; Benkel I; Syrbe S; Sheidley B; Guerrini R; Poduri A; Lemke JR; Mandelstam S; Scheffer I; Angriman M; Striano P; Marini C; Suls A; De Jonghe P;
    Neurology; 2013 Nov; 81(19):1697-703. PubMed ID: 24107868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A patient with early myoclonic encephalopathy (EME) with a de novo KCNQ2 mutation.
    Kojima K; Shirai K; Kobayashi M; Miyauchi A; Saitsu H; Matsumoto N; Osaka H; Yamagata T
    Brain Dev; 2018 Jan; 40(1):69-73. PubMed ID: 28687180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biallelic variants of KCNQ2 in early infantile developmental and epileptic encephalopathy.
    Zhang YJ; Wang TS; Zhu XM; Yu LF; Zhang LM; Zhou YF; Wang Y; Zhou SZ
    Seizure; 2024 Mar; 116():159-161. PubMed ID: 36934001
    [No Abstract]   [Full Text] [Related]  

  • 19. Gabapentin treatment in a patient with KCNQ2 developmental epileptic encephalopathy.
    Soldovieri MV; Freri E; Ambrosino P; Rivolta I; Mosca I; Binda A; Murano C; Ragona F; Canafoglia L; Vannicola C; Solazzi R; Granata T; Castellotti B; Messina G; Gellera C; Labalme A; Lesca G; DiFrancesco JC; Taglialatela M
    Pharmacol Res; 2020 Oct; 160():105200. PubMed ID: 32942014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time-limited alterations in cortical activity of a knock-in mouse model of KCNQ2-related developmental and epileptic encephalopathy.
    Biba-Maazou N; Becq H; Pallesi-Pocachard E; Sarno S; Granjeaud S; Montheil A; Kurz M; Villard L; Milh M; Santini PL; Aniksztejn L
    J Physiol; 2022 May; 600(10):2429-2460. PubMed ID: 35389519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.